- Home
- UFG vs LXRX Comparison
UFG vs LXRX Comparison
Compare UFG & LXRX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- UFG
- LXRX
- Stock Information
- Founded
- UFG 2021
- LXRX 1995
- Country
- UFG Singapore
- LXRX United States
- Employees
- UFG N/A
- LXRX N/A
- Industry
- UFG Oil Refining/Marketing
- LXRX Biotechnology: Pharmaceutical Preparations
- Sector
- UFG Energy
- LXRX Health Care
- Exchange
- UFG Nasdaq
- LXRX Nasdaq
- Market Cap
- UFG 149.8M
- LXRX 124.4M
- IPO Year
- UFG 2025
- LXRX 2000
- Fundamental
- Price
- UFG $4.91
- LXRX $0.70
- Analyst Decision
- UFG
- LXRX Buy
- Analyst Count
- UFG 0
- LXRX 4
- Target Price
- UFG N/A
- LXRX $3.67
- AVG Volume (30 Days)
- UFG 365.0K
- LXRX 5.7M
- Earning Date
- UFG 01-01-0001
- LXRX 05-13-2025
- Dividend Yield
- UFG N/A
- LXRX N/A
- EPS Growth
- UFG N/A
- LXRX N/A
- EPS
- UFG 0.01
- LXRX N/A
- Revenue
- UFG $155,193,013.00
- LXRX $31,081,000.00
- Revenue This Year
- UFG N/A
- LXRX N/A
- Revenue Next Year
- UFG N/A
- LXRX $84.78
- P/E Ratio
- UFG $927.51
- LXRX N/A
- Revenue Growth
- UFG 119.24
- LXRX 2481.48
- 52 Week Low
- UFG $3.50
- LXRX $0.28
- 52 Week High
- UFG $6.13
- LXRX $2.45
- Technical
- Relative Strength Index (RSI)
- UFG N/A
- LXRX 60.07
- Support Level
- UFG N/A
- LXRX $0.63
- Resistance Level
- UFG N/A
- LXRX $0.71
- Average True Range (ATR)
- UFG 0.00
- LXRX 0.07
- MACD
- UFG 0.00
- LXRX -0.00
- Stochastic Oscillator
- UFG 0.00
- LXRX 55.00
About UFG Uni-Fuels Holdings Limited Class A Ordinary Shares
Uni-Fuels Holdings Ltd is a service provider of marine fuels solutions. The company market, resell and brokers marine fuels products such as VLSFO, HSFO, and MGO. It offers these products to shipping companies and marine fuels suppliers in-port and offshore. In addition, the company may from time to time provide shipping-related services to its customers including but not limited to the arrangement of ship agents, ship provisions and marine fuels surveyors. It operates an integrated business model where It serves its customers through two operating models, sales of marine fuels solutions and brokerage.
About LXRX Lexicon Pharmaceuticals Inc.
Lexicon Pharmaceuticals Inc is a biopharmaceutical company. It is engaged in the discovery, development, and commercialization of pharmaceutical products for the treatment of human diseases. Some of its drug candidates are LX9211, an orally-delivered small molecule drug candidate, as a treatment for neuropathic pain; and sotagliflozin, an orally-delivered small molecule drug candidate, as a treatment for heart failure and type 1 diabetes.